https://boris-portal.unibe.ch/entities/publication/2877060f-7c27-46ac-b160-1d0c1ab5b75e
Raltegravir in second-line ART in resource-limited settings.
second lineraltegravirartresourcelimited
https://legalblogs.wolterskluwer.com/patent-blog/germany-raltegravir-federal-court-of-justice-of-germany-x-zb-217-11-july-2017/
Germany: Raltegravir, Federal Court of Justice of Germany, X ZB 2/17, 11 July 2017 | Kluwer Patent...
In this case the Federal Court of Justice (FCJ) allowed a compulsory licence under a patent for a pharmaceutical active ingredient for the first time ever. The...
https://pubmed.ncbi.nlm.nih.gov/32722897/
Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global...
Among children in LMICs, the initial use of raltegravir has been primarily for post PI-based cART. We found good virological and immunological outcomes despite...
https://adisinsight.springer.com/drugsafety/803273829?error=cookies_not_supported&code=948e1433-c627-4b99-b790-47b1e4eba188
Dolutegravir/elvitegravir/raltegravir - AdisInsight
In an observational single-centre study, three patients [1 woman and 2 men; exact ages not stated] were described who developed resistance to raltegravir and
dolutegravirelvitegravirraltegraviradisinsight
https://pubmed.ncbi.nlm.nih.gov/21402547/
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated,...
randomized controlled trialraltegravirintensificationantiretroviraltreated
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbd3e1af-81f3-44f6-8e45-652deab7a508&audience=consumer
DailyMed - ISENTRESS- raltegravir tablet, film coated
dailymedisentressraltegravirtabletfilm
https://adisinsight.springer.com/trials/700035782?error=cookies_not_supported&code=5d16eb03-d245-4fb5-a863-67a1ee7631e2
HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy. - AdisInsight
This study is designed to determine how quickly HIV-1 is cleared from the blood in treatment-experienced patients beginning a salvage therapy regimen that
hivviraldynamicssubjectsinitiating
https://pubmed.ncbi.nlm.nih.gov/24349334/
Genetic and non-genetic determinants of raltegravir penetration into cerebrospinal fluid: a single...
ClinicalTrials.gov NCT00729924 http://clinicaltrials.gov/show/NCT00729924.
https://adisinsight.springer.com/drugsafety/803113502?error=cookies_not_supported&code=d6e61d16-5044-49af-b214-d1f21ea157d9
Raltegravir - AdisInsight
A 57-year-old man developed DRESS syndrome following treatment with raltegravir for HIV infection. The man was administered raltegravir for advanced HIV disease
raltegraviradisinsight
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-to-market-msds-hiv-drug-raltegravir-in-india/articleshow/30723869.cms?from=mdr
Cipla to market MSD's HIV drug 'raltegravir' in India - The Economic Times
MSD in India Managing Director K G Ananthakrishnan said the partnership is aligned with the company's commitment towards patients in India.
https://adisinsight.springer.com/trials/700238855?error=cookies_not_supported&code=a48dbfbd-4f88-4482-a6b8-bb73d29d0a70
Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects...
This study will investigate the effects of co-administration of raltegravir and citalopram on the pharmacokinetics of both drugs in volunteers. Tolerability
drug interactionpharmacokineticstudy
https://researchdiscovery.drexel.edu/esploro/outputs/journalArticle/No-Effect-of-Raltegravir-Intensification-on/991019335326304721
No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of...
Mar 1, 2012 - Background: Controversy continues regarding the extent of ongoing viral replication in HIV-1-infected patients on effective antiretroviral therapy (ART)....
no effect
https://pubmed.ncbi.nlm.nih.gov/30999834/
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and...
Raltegravir (RAL) is an HIV-1 integrase strand transfer inhibitor that is well established as a component of highly active antiretroviral therapy regimens for...
efficacy and safetyin treatmentabacavir